How BMS is Doing RBM (Risk-Based Monitoring)

Published on: 

Pharmaceutical Executive

At this year’s Bio IT World Conference, Thomas Verish, Group Director of Data Operations Services at Bristol-Myers Squibb,

At this year’s Bio IT World Conference, Thomas Verish, Group Director of Data Operations Services at Bristol-Myers Squibb, elaborated on BMS’s risk-based monitoring (RBM) pilot, and how they are leveraging data, statistical analysis and personnel to execute RBM.

Advertisement

In this Applied Clinical Trials blog, Moe Alsumidale outlines the BMS’s RBM infrastructure.